Virbac SA develops, manufactures, and sells medicines and vaccines to enhance the health of food-producing animals. The company's products comprise Activyl, a spot-on solution used to treat and prevent flea infestations in dogs and cats; Activyl Tick Plus, a spot-on solution; Agrimin, a food supplement for cattle; Browse Plus, a food supplement; Circovirus vaccine, a vaccine against porcine circovirus; Cortavance, a hydrocortisone aceponate-based corticoid spray; Curacef duo, an injectable suspension; Easotic for otitis in dogs; Ectoadvance Plus, a topical external parasiticide; and Effipro duo, a spot-on solution for dogs and cats. Its products also include Effitix to treat tick, flea, and mosquito infestations in dogs; Epiotic, an ear cleanser; Equimax and Eraquell, a horse wormer; Floron to treat respiratory diseases in cattle; Iverhart, a chewable tablet; Milpro, an internal parasiticide tablet; Multimin, a trace element injectable supplement; Neoprinil, an eprinomectin-based pour-on solution; Nutribond, a palatable oral solution; Nutri-plus gel, a food supplement; and Orastrip, a diagnostic test. In addition, its products comprise Ostovet, a food supplement; Prinovox, a ectoparasiticide; Pronefra, a food supplement; Rilexine, a cephalexin-based antibiotic; Sentinel Flavor Tabs and Sentinel Spectrum, a polyvalent parasiticide tablet; Soloxine, a hormone prescribed for treating canine hypothyroidism; Speed, a range of rapid diagnostic tests; Speed Trio FeLV/FIV/Corona, a combined diagnostic test; Suigen, a range of swine vaccines; Suprelorin, a deslorelin-based implant for the induction of temporary infertility in male dogs; Veterin 50%, a spectrum antibiotic; Vet Complex/Veterinary HPM, a petfood; Virbagest, an altrenogest-based progestin; Zenifel, a fogger and spray; and Zoletil, a multi-species general anaesthetic. Further, it provides contract manufacturing services. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Show more
São Paulo, BR
Size (employees)
4,852 (est)+2%
Virbac was founded in 1968 and is headquartered in São Paulo, BR
Report incorrect company information

Virbac Office Locations

Virbac has an office in São Paulo
São Paulo, BR (HQ)
1368 Avenida Engenheiro E. Stevaux
Show all (1)
Report incorrect company information

Virbac Financials and Metrics

Virbac Financials

Market capitalization (22-Mar-2017)

1.2 b

Closing share price (22-Mar-2017)

Virbac's current market capitalization is €1.2 b.
Show all financial metrics
Report incorrect company information

Virbac News and Updates

Flavoured Veterinary Medications Market to Reflect Steady Growth Rate by 2021

North America is the largest market for flavored veterinary medications and is contributing the most as compared to other regions. Europe and Asia Pacific is the growing region in the forecast period. Posted via Industry Today. Follow us on Twitter @IndustryToday

Animal Parasiticides Market Substantial Growth Opportunities by 2023

Transparency Market Research offers meticulously researched market studies backed by 4 million hours of research experience. Currently handling over 350 client queries each day, it covers over 60 countries around the world. Also, 1.2 million data points are captured each year. Posted via Industry T…
Report incorrect company information